Effect of the serotonin reuptake inhibitor fluoxetine on corticotropin-releasing factor and vasopressin secretion into hypophysial portal blood

Daniel M. Gibbs, Wylie Vale

Research output: Contribution to journalArticle

166 Citations (Scopus)

Abstract

The relative role of corticotropin-releasing factor (CRF) and arginine vasopressin (AVP) in mediating serotonin-induced ACTH secretion was studied using the serotonin reuptake inhibitor fluoxetine. Fluoxetine caused a significant increase in ACTH and AVP concentrations in peripheral plasma as well as a significant increase in CRF and AVP concentrations in hypophysial portal plasma. The data suggest that increased secretion of ACTH induced by fluoxetine is mediated, at least in part, by an increase in the hypothalamic secretion of both CRF and AVP.

Original languageEnglish (US)
Pages (from-to)176-179
Number of pages4
JournalBrain Research
Volume280
Issue number1
DOIs
StatePublished - Nov 28 1983

Fingerprint

Arginine Vasopressin
Fluoxetine
Corticotropin-Releasing Hormone
Serotonin Uptake Inhibitors
Vasopressins
Adrenocorticotropic Hormone
Serotonin

Keywords

  • ACTH
  • CRF
  • fluoxetine
  • hypophysial portal blood
  • serotonin
  • vasopressin

ASJC Scopus subject areas

  • Developmental Biology
  • Molecular Biology
  • Clinical Neurology
  • Neuroscience(all)

Cite this

Effect of the serotonin reuptake inhibitor fluoxetine on corticotropin-releasing factor and vasopressin secretion into hypophysial portal blood. / Gibbs, Daniel M.; Vale, Wylie.

In: Brain Research, Vol. 280, No. 1, 28.11.1983, p. 176-179.

Research output: Contribution to journalArticle

@article{ab84b00e08e740c4aa9fb6dfa94cb304,
title = "Effect of the serotonin reuptake inhibitor fluoxetine on corticotropin-releasing factor and vasopressin secretion into hypophysial portal blood",
abstract = "The relative role of corticotropin-releasing factor (CRF) and arginine vasopressin (AVP) in mediating serotonin-induced ACTH secretion was studied using the serotonin reuptake inhibitor fluoxetine. Fluoxetine caused a significant increase in ACTH and AVP concentrations in peripheral plasma as well as a significant increase in CRF and AVP concentrations in hypophysial portal plasma. The data suggest that increased secretion of ACTH induced by fluoxetine is mediated, at least in part, by an increase in the hypothalamic secretion of both CRF and AVP.",
keywords = "ACTH, CRF, fluoxetine, hypophysial portal blood, serotonin, vasopressin",
author = "Gibbs, {Daniel M.} and Wylie Vale",
year = "1983",
month = "11",
day = "28",
doi = "10.1016/0006-8993(83)91189-7",
language = "English (US)",
volume = "280",
pages = "176--179",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Effect of the serotonin reuptake inhibitor fluoxetine on corticotropin-releasing factor and vasopressin secretion into hypophysial portal blood

AU - Gibbs, Daniel M.

AU - Vale, Wylie

PY - 1983/11/28

Y1 - 1983/11/28

N2 - The relative role of corticotropin-releasing factor (CRF) and arginine vasopressin (AVP) in mediating serotonin-induced ACTH secretion was studied using the serotonin reuptake inhibitor fluoxetine. Fluoxetine caused a significant increase in ACTH and AVP concentrations in peripheral plasma as well as a significant increase in CRF and AVP concentrations in hypophysial portal plasma. The data suggest that increased secretion of ACTH induced by fluoxetine is mediated, at least in part, by an increase in the hypothalamic secretion of both CRF and AVP.

AB - The relative role of corticotropin-releasing factor (CRF) and arginine vasopressin (AVP) in mediating serotonin-induced ACTH secretion was studied using the serotonin reuptake inhibitor fluoxetine. Fluoxetine caused a significant increase in ACTH and AVP concentrations in peripheral plasma as well as a significant increase in CRF and AVP concentrations in hypophysial portal plasma. The data suggest that increased secretion of ACTH induced by fluoxetine is mediated, at least in part, by an increase in the hypothalamic secretion of both CRF and AVP.

KW - ACTH

KW - CRF

KW - fluoxetine

KW - hypophysial portal blood

KW - serotonin

KW - vasopressin

UR - http://www.scopus.com/inward/record.url?scp=0021089383&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021089383&partnerID=8YFLogxK

U2 - 10.1016/0006-8993(83)91189-7

DO - 10.1016/0006-8993(83)91189-7

M3 - Article

C2 - 6317143

AN - SCOPUS:0021089383

VL - 280

SP - 176

EP - 179

JO - Brain Research

JF - Brain Research

SN - 0006-8993

IS - 1

ER -